Eli Lilly vs Pfizer: Revenue Comparison
Eli Lilly (LLY) and Pfizer (PFE) are peers in GLP-1. Eli Lilly reported revenue of $19.8B as of Q1 2026, compared with $14.5B for Pfizer. Eli Lilly leads on revenue.
Eli Lilly's gross margin is 81.9% versus 67.3% for Pfizer. Eli Lilly's net margin is 37.4% versus 18.6% for Pfizer.
Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q1 2026: Eli Lilly 19.799, Pfizer 14.451.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Eli Lilly, Pfizer.| Metric | Eli Lilly | Pfizer |
|---|---|---|
| Market Cap | - | - |
| Revenue | $19.80B | $14.45B |
| Cost of Revenue | $3.58B | $4.73B |
| Gross Profit | $16.22B | $9.72B |
| Operating Income | $8.85B | $4.03B |
| Net Income | $7.40B | $2.69B |
| R&D Expense | $3.51B | $2.63B |
| Earnings Per Share | $8.26 | $0.47 |
| Gross Margin | 81.9% | 67.3% |
| Operating Margin | 44.7% | 27.9% |
| Net Profit Margin | 37.4% | 18.6% |
| Free Cash Flow | $3.01B | $2.18B |
| Cumulative Free Cash Flow | $101.90B | $356.40B |
| Operating Cash Flow | $5.33B | $2.62B |
| Cash & Equivalents | $5.14B | $1.70B |